Meiqi Duan
Overview
Explore the profile of Meiqi Duan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
132
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zhang F, Guo J, Yu S, Zheng Y, Duan M, Zhao L, et al.
Cancer Commun (Lond)
. 2024 Jul;
44(9):929-966.
PMID: 38997794
The intrinsic oncogenic mechanisms and properties of the tumor microenvironment (TME) have been extensively investigated. Primary features of the TME include metabolic reprogramming, hypoxia, chronic inflammation, and tumor immunosuppression. Previous...
2.
Zhao L, Guo J, Xu S, Duan M, Liu B, Zhao H, et al.
J Adv Res
. 2024 Apr;
PMID: 38677545
Background: N6-methyladenosine (mA) RNA methylation modifications have been widely implicated in the metabolic reprogramming of various cell types within the tumor microenvironment (TME) and are essential for meeting the demands...
3.
Guo J, Zhao L, Duan M, Yang Z, Zhao H, Liu B, et al.
Biomed Pharmacother
. 2024 Mar;
174:116479.
PMID: 38537580
RNA methylation modifications are widespread in eukaryotes and prokaryotes, with N-methyladenosine (mA) the most common among them. Demethylases, including Fat mass and obesity associated gene (FTO) and AlkB homolog 5...
4.
Duan M, Liu H, Xu S, Yang Z, Zhang F, Wang G, et al.
Genes Dis
. 2023 Sep;
11(2):890-920.
PMID: 37692485
mA methylation is the most frequent modification of mRNA in eukaryotes and plays a crucial role in cancer progression by regulating biological functions. Insulin-like growth factor 2 mRNA-binding proteins (IGF2BP)...
5.
Zhang Z, Zhou X, Guo J, Zhang F, Qian Y, Wang G, et al.
J Transl Med
. 2022 Jul;
20(1):320.
PMID: 35842634
As an important component of the immunosuppressive tumor microenvironment (TME), it has been established that mesenchymal stem cells (MSCs) promote the progression of tumor cells. MSCs can directly promote the...
6.
Zhang F, Liu H, Duan M, Wang G, Zhang Z, Wang Y, et al.
J Hematol Oncol
. 2022 Jul;
15(1):84.
PMID: 35794625
The tumor microenvironment (TME), which is regulated by intrinsic oncogenic mechanisms and epigenetic modifications, has become a research hotspot in recent years. Characteristic features of TME include hypoxia, metabolic dysregulation,...
7.
Zhang F, Guo J, Zhang Z, Duan M, Wang G, Qian Y, et al.
J Biomed Sci
. 2022 Feb;
29(1):14.
PMID: 35189894
All cells, including prokaryotes and eukaryotes, could release extracellular vesicles (EVs). EVs contain many cellular components, including RNA, and surface proteins, and are essential for maintaining normal intercellular communication and...
8.
Zhang F, Guo J, Zhang Z, Qian Y, Wang G, Duan M, et al.
Cancer Lett
. 2021 Nov;
526:29-40.
PMID: 34800567
Mesenchymal stem cells (MSCs) are multipotent stromal cells that have the ability to differentiate into multiple cell types. Several studies have shown that exosomes secreted by MSCs (MSCs-Exo) play an...